1
|
Bujan L, Nouri N, Papaxanthos-Roche A, Ducrocq B, Brugnon F, Ravel C, Rives N, Teletin M, Drouineaud V, Delepine B, Berthaut I, Metzler-Guillemain C, Devaux A, Frapsauce C, Thibault E, Blagosklonov O, Clarotti MA, Diligent C, Loup Cabaniols V, Fauque P, Benchaib M, Eustache F, Daudin M. Motivations and personality characteristics of candidate sperm and oocyte donors according to parenthood status: a national study from the french CECOS network. Hum Reprod Open 2022; 2022:hoac042. [PMID: 36382009 PMCID: PMC9641712 DOI: 10.1093/hropen/hoac042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2022] [Revised: 07/20/2022] [Indexed: 12/03/2022] Open
Abstract
STUDY QUESTION In a non-commercial national gamete donation programme, do the motivations and personality characteristics of candidate sperm and oocyte donors differ according to their parenthood status? SUMMARY ANSWER Moderate differences exist between non-parent and parent candidate donors in motivations for gamete donation and representations as well as in personality characteristics. WHAT IS KNOWN ALREADY Several studies have analysed the motivations and experiences of oocyte or sperm donors, but mainly in countries where gamete donation is a commercial transaction, and very few studies have reported results of personality traits using personality inventory tests. No study has specifically investigated the motivations and personality characteristics of candidate gamete donors according to parenthood status. STUDY DESIGN, SIZE, DURATION A prospective study was carried out including 1021 candidate donors from 21 centres (in university hospitals) of the national sperm and egg banking network in France between November 2016 and December 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS In total, 1021 candidate gamete donors were included in the study. During their first visit, male (n = 488) and female candidate donors (n = 533) completed a questionnaire on sociodemographic characteristics, their motivations for donation and their representations of donation, infertility and family. Secondly, a NEO Personality Inventory (NEO-PI-R) exploring the Big Five personality traits was completed online. Results were compared between parent and non-parent candidate donors. MAIN RESULTS AND THE ROLE OF CHANCE Altruistic values were the principal motive for donation irrespective of parenthood status. Reassurance about their fertility or preservation of sperm for future use was more often reported in non-parent than in parent candidate donors. With regard to representation of gamete donation or of the family, independently of their parenthood status, candidate donors more frequently selected social rather than biological representations. Mean personality characteristics were in the normal range. Non-parent candidate donors had higher scores on openness and depression than parents, while parent candidate donors appeared more social than non-parents. LIMITATIONS, REASONS FOR CAUTION The personality characteristics inventory was not completed by all candidate donors included in the study. However, family status did not differ between the two groups (NEO-PI-R completed (n = 525) or not), while the group who completed the NEO-PI-R had a higher educational level. This national study was performed in a country where gamete donation is subject to strict legislation. WIDER IMPLICATIONS OF THE FINDINGS In a global context where reproductive medicine is commercialized and gamete donor resources are limited, this study found that altruism and social representations of gamete donation and family are the main motivations for gamete donation in a country which prohibits financial incentive. These findings are relevant for health policy and for gamete donation information campaigns. STUDY FUNDING/COMPETING INTEREST(S) Grant from the Agence de la Biomédecine, France. The authors have nothing to disclose related to this study. TRIAL REGISTRATION NUMBER N/A.
Collapse
Affiliation(s)
- L Bujan
- CHU de Toulouse CECOS—Service de Médecine de la Reproduction, , Toulouse, France
- DEFE UMR Inserm 1203, Universités de Montpellier et Toulouse , Toulouse, France
| | - N Nouri
- CHU de Toulouse CECOS—Service de Médecine de la Reproduction, , Toulouse, France
- DEFE UMR Inserm 1203, Universités de Montpellier et Toulouse , Toulouse, France
| | - A Papaxanthos-Roche
- Service de Biologie de la Reproduction, CECOS de Bordeaux , CHU Bordeaux, France
| | - B Ducrocq
- Hôpital Calmette, CHU Lille CECOS Nord, , France, Lille
| | - F Brugnon
- CHU Clermont-Ferrand AMP-CECOS Clermont-Ferrand, , France, Clermont-Ferrand
- Université Clermont Auvergne INSERM 1240, , Clermont-Ferrand, France
| | - C Ravel
- CHU Rennes CECOS Rennes, , France, Rennes
| | - N Rives
- Rouen University Hospital EA 4308 Gametogenesis and Gamete Quality, , Biology of Reproduction-CECOS Laboratory, Rouen, France
| | - M Teletin
- CHRU de Strasbourg CECOS Alsace, , France, Schiltigheim
| | - V Drouineaud
- Service de Biologie de la Reproduction-CECOS, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris , Paris, France
| | - B Delepine
- CHU de Reims CECOS Champagne-Ardenne, Service de Biologie de la Reproduction, , Reims, France
| | - I Berthaut
- Service de Biologie de la Reproduction-CECOS, Hôpital Tenon, AP-HP, Sorbonne Université , Paris, France
- INSERM UMRS 938, Centre de Recherche Saint-Antoine , Paris, France
| | - C Metzler-Guillemain
- Centre Clinico-Biologique AMP-CECOS Assistance-Publique, des Hôpitaux de Marseille, La Conception, , Marseille, France
| | - A Devaux
- CHU Picardie CECOS Amiens, , France, Amiens
| | - C Frapsauce
- CECOS Centre Tours, CHRU Hôpitaux de Tours , Tours, France
| | - E Thibault
- CECOS Provence-Alpes-Côte d’Azur, CHU de Nice , Nice, France
| | - O Blagosklonov
- CECOS Franche-Comté Bourgogne Besançon, CHU Jean Minjoz , Besançon, France
| | - M A Clarotti
- CECOS Caen Basse Normandie, CHU Caen , Caen, France
| | - C Diligent
- CECOS de Nancy, Centre d'AMP, CHRU de Nancy , Nancy, France
| | - V Loup Cabaniols
- CECOS Languedoc Roussillon Montpellier, CHU Montpellier , Montpellier, France
| | - P Fauque
- CECOS Franche-Comté Bourgogne, CHU Dijon , Dijon, France
| | - M Benchaib
- CECOS Rhône-Alpes Lyon, Hospices Civils de Lyon , Bron, France
| | - F Eustache
- CECOS Paris-Jean Verdier, AP-HP , Bondy, France
| | - M Daudin
- CHU de Toulouse CECOS—Service de Médecine de la Reproduction, , Toulouse, France
- DEFE UMR Inserm 1203, Universités de Montpellier et Toulouse , Toulouse, France
| |
Collapse
|
2
|
Fauque P, Frappier J, Barberet J, Bruno C, Cavalieri M, Braquehais N, Chamoy B, Brualla A, Bergelson N, Hickman C. Use of CHLOE-EQ to select embryos for transfer at the Cleavage stage: a pilot study using paired sibling embryos with known implantation. Reprod Biomed Online 2022. [DOI: 10.1016/j.rbmo.2022.08.082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/07/2022]
|
3
|
Epelboin S, Labrosse J, Fauque P, Levy R, Mouzon JD, Boyer M, Vienne CD, Bergere M, Valentin M, Devaux A, Hester L, Sermondade N, Jonveaux P, Pessione1 F. O-182 Higher risk of preeclampsia and pregnancy-induced hypertension with artificial cycle for Frozen-thawed Embryo Transfer compared to ovulatory cycle or fresh transfer following In Vitro Fertilization. Hum Reprod 2021. [DOI: 10.1093/humrep/deab127.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
Is there an increased risk of preeclampsia after Frozen-thawed Embryo Transfer(FET) compared to In Vitro Fertilization-fresh transfer(IVF-fresh-ET) according to endometrial type of preparation for FET?
Summary answer
The frequency of preeclampsia and hypertension were significantly higher in the group of artificial cycle (AC-FET) compared to ovulatory cycle (OC-FET) and fresh-ET (P < 0.0001).
What is known already
Risks of maternal morbidity are known to be reduced in pregnancies resulting from FET compared to fresh-ET except for the risk of preeclampsia, that was reported to be significantly higher in pregnancies resulting from FET compared to fresh-ET or spontaneous conception. Most recent studies demonstrate an equal live birth rate with either OC-FET or AC-FET preparation. Few studies compared the maternal vascular morbidities with the two hormonal environments that preside over the early stages of embryonic development: OC (major role of the corpus luteum) and AC (prolonged hormone replacement with high doses of estrogen and progesterone).
Study design, size, duration
We conducted a 2013-2018 French nationwide cohort study comparing maternal vascular morbidities in 3 groups of single pregnancies> 22 weeks of gestation (WG): FET with AC or OC preparation, and IVF (conventional or ICSI)-fresh-ET.Data were extracted from the French National Health System database (>99% of national deliveries) in which all hospitalizations are registered, containing information on patient characteristics, diagnoses and treatments. Records were merged anonymously. Access to the database was legally approved.
Participants/materials, setting, methods
68 025 deliveries were included: fresh-ET(n = 48 152), OC-FET(n = 9 500), AC-FET(n = 10 373). In OC-FET, a luteal phase support with progesterone was administered for maximum 6 WG if pregnancy. In AC-FET, progesterone was co-administered with estrogen until 12 WG. Embryos were transferred at cleavage or blastocyst stage.
Vascular disorders were recorded if hospitalization for preeclampsia/eclampsia or hypertension (history of hypertension excluded). Maternal characteristics were included in multivariate analysis. Adjusted odds ratios(aOR) and 95% confidence intervals(CI) were estimated.
Main results and the role of chance
Maternal characteristics: In multivariate analysis, patients in the FET groups were older (33.4 years (std=4.3) vs. 33.2 years (std=4.4) for fresh-ET, respectively, P < 0.0001), less often primiparous (aOR=0.68[0.66-0.71], P < 0.0001) or smokers (aOR=0.84[0.75-0.95]) or with premature ovarian insufficiency (POI) (aOR=0.68 [0.58-0.79]), more frequently with polycystic ovaries (PCOS) (aOR=1.25[1.12-1.39]) and comparable for obesity or diabetes.
In FET groups, 52.2% were AC-FET. There was no difference for maternal age, parity, obesity, smoking, history of diabetes between AC and OC-FET. Endometriosis (aOR=1.26[1.16-1.38]), PCOS (aOR=1.79[1.50-2.15]) and POI (aOR=2.0[1.48-2.72]) were more frequent in AC-FET.
Risks of vascular disorders
The rate of preeclampsia (5.3% vs. 2.3% vs. 2.4%, respectively, P < 0.0001) and hypertension (4.7% vs. 3.4% vs. 3.3%, respectively, P = 0.0002) was significantly higher in AC-FET versus OC-FET and fresh-ET.
In multivariate analysis, the risk of preeclampsia increased with age, primiparity, obesity, diabetes and POI. The risk was higher in AC-FET versus OC-FET (aOR=2.42 [2.06-2.85]) and fresh-ET (aOR=2.43[2.2-2.7]), P < 0.00001. No difference was found between OC-FET and fresh-ET (P = 0.91). The risk of pregnancy-induced hypertension increased with age >40, primiparity, smoking, obesity and diabetes and was higher in AC-FET versus OC-FET (aOR=1.50[1.29-1.74], P < 0.0001) and fresh-ET (aOR=1.50[1.35-1.67], P < 0.0001) and not different between OC-FET and fresh-ET (P = 0.86).
Limitations, reasons for caution
While the strength of this study relies in the number and exhaustiveness of subjects analysed, its limitations are its retrospective and register-based nature that did not enable to refine the risk according to details of techniques and treatments in each group.
Wider implications of the findings
This large nationwide cohort study highlights 2 important information for physicians : i) the possible deleterious role of high supra-physiological and prolonged doses of estrogen-progesterone supplementation on vascular pathologies ii) the protective role of the corpus luteum present in stimulated or spontaneous OC for their prevention.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- S Epelboin
- Assistance Publique Hôpitaux de Paris Hôpital Bichat-Claude Bernard, Gynecology Obstetrics Reproductive Medecine, Paris, France
| | - J Labrosse
- Assistance Publique Hôpitaux de Paris Hôpital Jean Verdier, Gynecology Obstetrics Reproductive Medecine, Paris, France
| | - P Fauque
- Université Bourgogne Franche-Comté - INSERM UMR1231- 2 Rue Angélique Ducoudray- F-21000 Dijon- France, Embryology, Dijon, France
| | - R Levy
- Assistance Publique Hôpitaux de Paris Hôpital Tenon, Embryology, Paris, France
| | | | - M Boyer
- Hôpital Saint-Joseph- Marseille, reproductive medecine, Marseille, France
| | - C. De Vienne
- Agence de la Biomédecine, Epidemiology, Saint-Denis, France
| | - M Bergere
- Agence de la Biomédecine, Epidemiology, Saint-Denis, France
| | - M Valentin
- Assistance Publique Hôpitaux de Paris Hôpital Bichat-Claude Bernard, Gynecology Obstetrics Prenatal diagnosis, Paris, France
| | - A Devaux
- Assistance Publique Hôpitaux de Paris, Embryology, Paris, France
| | - L Hester
- Assistance Publique Hôpitaux de Paris Hôpital Antoine Beclere, Embryology, Paris, France
| | - N Sermondade
- Assistance Publique Hôpitaux de Paris Hôpital Tenon, Embryology, Paris, France
| | - P Jonveaux
- Agence de la Biomédecine, Epidemiology genetics, Saint-Denis, France
| | - F Pessione1
- Assistance Publique Hôpitaux de Paris Hôpital Jean Verdier, Gynecology Obstetrics Reproductive Medecine, Paris, France
| |
Collapse
|
4
|
Barberet J, Binquet C, Guilleman M, Doukani A, Choux C, Bruno C, Bourredjem A, Chapusot C, Bourc'his D, Duffourd Y, Fauque P. Do assisted reproductive technologies and in vitro embryo culture influence the epigenetic control of imprinted genes and transposable elements in children? Hum Reprod 2021; 36:479-492. [PMID: 33319250 DOI: 10.1093/humrep/deaa310] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2020] [Revised: 09/10/2020] [Indexed: 11/15/2022] Open
Abstract
STUDY QUESTION Do assisted reproductive technologies (ART) and in vitro embryo culture influence the epigenetic control of imprinted genes (IGs) and transposable elements (TEs) in children? SUMMARY ANSWER Significant differences in the DNA methylation of IGs or transposon families were reported between ART and naturally conceived children, but there was no difference between culture media. WHAT IS KNOWN ALREADY There is concern that ART may play a role in increasing the incidence of adverse health outcomes in children, probably through epigenetic mechanisms. It is crucial to assess epigenetic control, especially following non-optimal in vitro culture conditions and to compare epigenetic analyses from ART-conceived and naturally conceived children. STUDY DESIGN, SIZE, DURATION This follow-up study was based on an earlier randomized study comparing in vitro fertilization outcomes following the use of two distinct culture media. We compared the epigenetic profiles of children from the initial randomized study according to the mode of conception [i.e. ART singletons compared with those of a cohort of naturally conceived singleton children (CTL)], the type of embryo culture medium used [global medium (LifeGlobal) and single step medium (Irvine Scientific)] and the mode of in vitro fertilization (i.e. IVF versus ICSI). PARTICIPANTS/MATERIALS, SETTING, METHODS A total of 57 buccal smears were collected from 7- to 8-year-old children. The DNA methylation profiles of four differentially methylated regions (DMRs) of IGs (H19/IGF2: IG-DMR, KCNQ1OT1: TSS-DMR, SNURF: TSS-DMR, and PEG3: TSS-DMR) and two TEs (AluYa5 and LINE-1) were first assessed by pyrosequencing. We further explored IGs and TEs' methylation changes through methylation array (Human MethylationEPIC BeadChip referred as EPIC array, Illumina). MAIN RESULTS AND THE ROLE OF CHANCE Changes in the IGs' DNA methylation levels were found in ART children compared to controls. DNA methylation levels of H19/IGF2 DMR were significantly lower in ART children than in CTL children [52% versus 58%, P = 0.003, false discovery rate (FDR) P = 0.018] while a significantly higher methylation rate was observed for the PEG3 DMR (51% versus 48%, P = 0.007, FDR P = 0.021). However, no differences were found between the culture media. After observing these targeted modifications, analyses were performed at wider scale. Again, no differences were detected according to the culture media, but imprinted-related DMRs overlapping promoter region near the genes major for the development (MEG3, BLCAP, and DLX5) were detected between the ART and CTL children. LIMITATIONS, REASONS FOR CAUTION The sample size could seem relatively small, but the high consistency of our results was ensured by the homogeneity of the cohort from the initial randomized study, the standardized laboratory techniques and the robust statistical analyses accounting for multiple testing. WIDER IMPLICATIONS OF THE FINDINGS Although this study did not report DNA methylation differences depending on the culture medium, it sheds light on epigenetic changes that could be observed in some children conceived by ART as compared to CTL children. The clinical relevance of such differences remains largely unknown, and it is still unclear whether such changes are due to some specific ART procedures and/or to parental infertility. STUDY FUNDING/COMPETING INTEREST(S) This work was supported by funding from the Agence Nationale pour la Recherche ('CARE'-ANR JCJC 2017). The authors have no conflicts of interest. TRIAL REGISTRATION NUMBER Not concerned.
Collapse
Affiliation(s)
- J Barberet
- Université Bourgogne Franche-Comté-Equipe Génétique des Anomalies du Développement (GAD) INSERM UMR1231, Dijon, France.,CHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction-CECOS, Dijon, France
| | - C Binquet
- CHU Dijon Bourgogne, Centre d'Investigation Clinique, module Epidémiologie Clinique/essais cliniques (CIC-EC), Dijon, France.,INSERM, CIC1432, module épidémiologie clinique, Dijon, France
| | - M Guilleman
- Université Bourgogne Franche-Comté-Equipe Génétique des Anomalies du Développement (GAD) INSERM UMR1231, Dijon, France.,CHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction-CECOS, Dijon, France
| | - A Doukani
- Faculté de Médecine Sorbonne Université, Site Pitié-Salpêtrière, Paris, France
| | - C Choux
- Université Bourgogne Franche-Comté-Equipe Génétique des Anomalies du Développement (GAD) INSERM UMR1231, Dijon, France.,CHU Dijon Bourgogne, Service de Gynécologie-Obstétrique, Dijon, France
| | - C Bruno
- Université Bourgogne Franche-Comté-Equipe Génétique des Anomalies du Développement (GAD) INSERM UMR1231, Dijon, France.,CHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction-CECOS, Dijon, France
| | - A Bourredjem
- CHU Dijon Bourgogne, Centre d'Investigation Clinique, module Epidémiologie Clinique/essais cliniques (CIC-EC), Dijon, France.,INSERM, CIC1432, module épidémiologie clinique, Dijon, France
| | - C Chapusot
- CHU Dijon Bourgogne, Plateforme de génétique des Cancers de bourgogne, Dijon, France
| | - D Bourc'his
- Institut Curie, PSL University, CNRS, INSERM, Paris, France
| | - Y Duffourd
- Université Bourgogne Franche-Comté-Equipe Génétique des Anomalies du Développement (GAD) INSERM UMR1231, Dijon, France
| | - P Fauque
- Université Bourgogne Franche-Comté-Equipe Génétique des Anomalies du Développement (GAD) INSERM UMR1231, Dijon, France.,CHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction-CECOS, Dijon, France
| |
Collapse
|
5
|
Moreau J, Gatimel N, Lippi Y, Tavenier G, Fauque P, Guilleman M, Naylies C, Huesca AA, Gayrard V, Parinaud J, Leandri RD. Impact of the polycarbonate strippers used in assisted reproduction techniques on embryonic development. Hum Reprod 2021; 36:331-339. [PMID: 33246333 DOI: 10.1093/humrep/deaa290] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 09/21/2020] [Indexed: 12/13/2022] Open
Abstract
STUDY QUESTION Do daily manipulations of preimplantation embryos with polycarbonate (PC)-made bisphenol A (BPA)-releasing strippers influence embryo development? SUMMARY ANSWER Compared to glass strippers, PC strippers enhance the blastocyst development rate but this does not seem to be BPA-related. WHAT IS KNOWN ALREADY PC strippers have been shown to release tiny amounts (around 0.5 ng/ml BPA) of BPA in routine human IVF procedures. A chronic exposure to BPA either in vivo or in vitro during the preimplantation period can impact post-implantation and post-natal development. BPA can act rapidly by binding to membrane receptors and inducing rapid non-genomic effects. STUDY DESIGN, SIZE, DURATION This experimental study using mouse embryos had a balanced design and blinded evaluations of the endpoints. PARTICIPANTS/MATERIALS, SETTING, METHODS In vivo fertilized zygotes were obtained from outbred Swiss CD1 mice crossings after an ovarian stimulation. The zygotes were allocated to three daily handling conditions (HCs) and cultured until Day 4 in a single human commercial medium. Each day, the embryos were handled for 20 s either in a PC stripper (HC1) or in a glass stripper (HC2). In HC3, the embryos were pre-exposed to 0.5 ng/ml BPA before being handled for 20 s in a glass stripper. Handling operations were repeated on Days 1, 2 and 3. Embryo development was assessed blindly on Day 4. Expanded blastocysts were selected for a transcriptomic analysis using Agilent Sureprint G3 Mouse GE v2 microarrays and the retrotransposon LINE1-Orf2 expression was analysed using qRT-PCR, as a proxy for a global evaluation of the epigenetic status. MAIN RESULTS AND THE ROLE OF CHANCE Compared to the embryos manipulated in HC2 (n = 243), those in HC1 (n = 228) developed significantly more often to the blastocyst stage (55 vs 46%; P < 0.05). It appears the effect of these PC strippers was not BPA-related because embryos pre-exposed to BPA (HC3, n = 230) showed no difference in the blastocyst rate when compared to HC2 (43 vs 46%). When analysing same-stage blastocysts, we noticed no difference in the embryo gene expression between the three HC groups. LARGE SCALE DATA https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE148868. LIMITATIONS, REASONS FOR CAUTION Our results using a mouse model designed to mimic human conditions (outbred strain, human commercial IVF dishes and a unique commercial human embryonic culture media) are reassuring since no gene was found to be differentially expressed, including LINE-1 genes, as a proxy for a global evaluation of the epigenetic status. However, no global epigenetic analysis of the genome has been performed. Furthermore, we did not evaluate post-implantation events, although BPA exposure during peri-conception could affect foeto-placental and post-natal development. WIDER IMPLICATIONS OF THE FINDINGS Based on the precautionary principle, several European countries banned the use of BPA in baby bottles and food packaging several years before European Agencies took an official position. The question of applying this principle to plastics in closed contact with human embryos is raised. Further studies are needed for a decision to be made. STUDY FUNDING/COMPETING INTEREST(S) This study was supported by a grant from the Agence de Biomédecine (AOR 2016). The authors declare no competing interest.
Collapse
Affiliation(s)
- J Moreau
- Department of Reproductive Medicine, Toulouse University Hospital, Toulouse, France.,EA 3694 Human Fertility Research Group, Paul Sabatier University, Toulouse, France
| | - N Gatimel
- Department of Reproductive Medicine, Toulouse University Hospital, Toulouse, France.,EA 3694 Human Fertility Research Group, Paul Sabatier University, Toulouse, France
| | - Y Lippi
- Toxalim (Research Center in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France
| | - G Tavenier
- Transgenesis core facility of UMS006/Inserm/Paul Sabatier University/National Medical Veterinary School, Toulouse cedex 1, France.,Inserm UMR 1048, Paul Sabatier University, Toulouse cedex 4, France
| | - P Fauque
- Université Bourgogne Franche-Comté-Equipe Génétique des Anomalies du Développement (GAD) INSERM UMR 1231, Dijon, France.,CHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction, Dijon, France
| | - M Guilleman
- Université Bourgogne Franche-Comté-Equipe Génétique des Anomalies du Développement (GAD) INSERM UMR 1231, Dijon, France.,CHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction, Dijon, France
| | - C Naylies
- Toxalim (Research Center in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France
| | - A A Huesca
- INTHERES, Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France
| | - V Gayrard
- ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France
| | - J Parinaud
- Department of Reproductive Medicine, Toulouse University Hospital, Toulouse, France.,EA 3694 Human Fertility Research Group, Paul Sabatier University, Toulouse, France
| | - R D Leandri
- Department of Reproductive Medicine, Toulouse University Hospital, Toulouse, France.,EA 3694 Human Fertility Research Group, Paul Sabatier University, Toulouse, France
| |
Collapse
|
6
|
Vassallo M, Manni S, Pini P, Blanchouin E, Ticchioni M, Seitz-Polski B, Puchois A, Sindt A, Lotte L, Fauque P, Durant J. Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation. Int J Infect Dis 2020; 101:174-179. [PMID: 33002623 PMCID: PMC7521203 DOI: 10.1016/j.ijid.2020.09.1438] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 09/22/2020] [Accepted: 09/22/2020] [Indexed: 02/07/2023] Open
Abstract
OBJECTIVES A novel beta coronavirus has been identified as responsible for the 2019 coronavirus infection (Covid-19). Clinical presentations range from asymptomatic cases to acute respiratory distress syndrome with fatal outcome. Such a broad spectrum of disease expression calls for an investigation of immune response characteristics. METHODS We identified subjects admitted for Covid-19 in whom a large panel of immunological markers were measured, including B- and T- and NK-lymphocyte phenotypes, T-lymphocyte subpopulation cells and plasma cytokines. Patients were divided according to symptom severity during hospitalisation, in those with uncomplicated and complicated infection. Differences between groups were analyzed. RESULTS Seventeen patients were included (mean age: 83 years; 9 women; mean delay of symptoms onset: 4 days). Six had uncomplicated infection, while 11 developed complicated forms during hospitalization. CD10 + B lymphocyte levels were inversely correlated with clinical severity (5.8% vs 2.0%, p = 0.04) and CD10+ levels above 3% were independently associated with uncomplicated forms [Odds Ratio 0.04 (CI 0.002-0.795, p = 0.034)]. TNF-alpha, IL-1, Il-6 and Il-8 measurements upon admission differed between patients who died and those who survived (p < 0.01 for all comparisons). CONCLUSIONS In a population of elderly patients recently infected with Covid-19, CD10 + B cell levels were inversely correlated with clinical severity. Cytokine values upon admission were highly predictive of fatal outcome during hospitalisation. These findings could explain differences in the clinical presentation and allow rapid identification of patients at risk for complications.
Collapse
Affiliation(s)
- M Vassallo
- Department of Internal Medicine/Infectious Diseases, Cannes General Hospital, Cannes, France.
| | - S Manni
- Department of Internal Medicine/Infectious Diseases, Cannes General Hospital, Cannes, France
| | - P Pini
- Department of Internal Medicine/Infectious Diseases, Cannes General Hospital, Cannes, France
| | - E Blanchouin
- Department of Internal Medicine/Infectious Diseases, Cannes General Hospital, Cannes, France
| | - M Ticchioni
- Laboratory of Immunology, Nice University Hospital, Université Côte d'Azur, Nice, France
| | - B Seitz-Polski
- Laboratory of Immunology, Nice University Hospital, Université Côte d'Azur, Nice, France
| | - A Puchois
- Multipurpose Laboratory, Bacteriology and Virology Unit, Cannes General Hospital, Cannes, France
| | - A Sindt
- Multipurpose Laboratory, Bacteriology and Virology Unit, Cannes General Hospital, Cannes, France
| | - L Lotte
- Multipurpose Laboratory, Bacteriology and Virology Unit, Cannes General Hospital, Cannes, France
| | - P Fauque
- Institut Polyclinique de Cannes (IPOCA), Cannes, France
| | - J Durant
- Infectious Diseases Department, Nive University Hospital, Université Côte d'Azur, Nice, France
| |
Collapse
|
7
|
Barberet J, Bruno C, Valot E, Antunes-Nunes C, Jonval L, Chammas J, Choux C, Ginod P, Sagot P, Soudry-Faure A, Fauque P. Can novel early non-invasive biomarkers of embryo quality be identified with time-lapse imaging to predict live birth? Hum Reprod 2020; 34:1439-1449. [PMID: 31287145 PMCID: PMC6688874 DOI: 10.1093/humrep/dez085] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2018] [Revised: 04/24/2019] [Accepted: 05/07/2019] [Indexed: 01/31/2023] Open
Abstract
STUDY QUESTION Can time-lapse imaging systems make it possible to identify novel early non-invasive biomarkers to predict live birth? SUMMARY ANSWER From mostly high-grade embryos, out of 35 morphometric, morphologic and morphokinetic variables, only pronuclei (PN) position at time of PN juxtaposition and the absence of multinucleated blastomeres at the 2-cell stage (MNB2cell), were potentially associated with live birth. WHAT IS KNOWN ALREADY Previous studies indicate that some kinetic markers may be predictive of blastocyst development and embryonic implantation. Certain teams have suggested including some of them in decisional algorithms for embryo transfers. STUDY DESIGN, SIZE, DURATION Using a time-lapse incubator (EmbryoScope, Unisense FertiliTech), we retrospectively explored the associations between the morphometric, morphologic and morphokinetic parameters of oocytes, zygotes and embryos, and their associations with live birth. This study assessed 232 embryos from single embryo transfers after ICSI cycles performed between January 2014 and December 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS The morphometric, morphologic and morphokinetic parameters (18, 4 and 13, respectively) of oocytes, zygotes and early embryos were studied retrospectively. The associations between these parameters were examined using a Spearman's correlation, Mann-Whitney or chi-squared test as appropriate. We examined whether these parameters were associated with outcomes in univariate and multivariate logistic regression analyses. MAIN RESULTS AND THE ROLE OF CHANCE Central PN juxtaposition was associated with a 2-fold increase in the odds of live birth (OR = 2.20; 95% CI, [1.26-3.89]; P = 0.006), while the presence of MNB2cell was associated with half the odds of live birth (OR = 0.51; 95% CI, [0.27-0.95]; P = 0.035). These two parameters were independent of embryo kinetics. The 33 remaining parameters had no significant association with the capacity of transferred embryos to develop to term. LIMITATIONS, REASONS FOR CAUTION Even though the population size was relatively small, our analyses were based on homogeneous cycles, i.e. young women whose transferred embryos were found to be high-grade according to conventional morphology evaluation. In addition, our conclusions were established from a specific, highly selected population, so other study populations, such as women in an older age bracket, may yield different results. Finally, because we assessed day 2/3 transfers, our findings cannot be generalized to embryos cultured up to the blastocyst stage. WIDER IMPLICATIONS OF THE FINDINGS It would be interesting to explore, prospectively, whether PN localisation is a relevant measure to predict embryo development when added into further algorithms and whether this parameter could be suitable for use in other IVF clinics. Further studies are needed, notably to explore the added value of timing evaluation in cohorts of embryos with low or intermediate morphology grade, as well as in other maternal populations (i.e. older women). STUDY FUNDING/COMPETING INTEREST(S) No external funding was used for this study. P. Sagot received funding from the following commercial companies: Merck Serono, Finox Biotech, Ferring, MSD France SAS, Teva Sante ́ SAS, Allergan France, Gedeon Richter France, Effik S.A., Karl Storz Endoscopie France, GE Medical Systems SCS, Laboratoires Genevrier, H.A.C. Pharma and Ipsen.All the authors confirm that none of this funding was used to support the research in this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the journal policies on sharing data and materials.
Collapse
Affiliation(s)
- J Barberet
- Laboratoire de Biologie de la Reproduction, Hôpital François Mitterrand, Université de Bourgogne, Dijon, France.,INSERM UMR1231, Université de Bourgogne Franche comté, Dijon, France
| | - C Bruno
- Laboratoire de Biologie de la Reproduction, Hôpital François Mitterrand, Université de Bourgogne, Dijon, France.,INSERM UMR1231, Université de Bourgogne Franche comté, Dijon, France
| | - E Valot
- Laboratoire de Biologie de la Reproduction, Hôpital François Mitterrand, Université de Bourgogne, Dijon, France
| | - C Antunes-Nunes
- Laboratoire de Biologie de la Reproduction, Hôpital François Mitterrand, Université de Bourgogne, Dijon, France
| | - L Jonval
- USMR, Dijon University Hospital, France
| | - J Chammas
- Laboratoire de Biologie de la Reproduction, Hôpital François Mitterrand, Université de Bourgogne, Dijon, France
| | - C Choux
- Service de Gynécologie-Obstétrique, Hôpital François Mitterrand, Université de Bourgogne, Dijon, France
| | - P Ginod
- Service de Gynécologie-Obstétrique, Hôpital François Mitterrand, Université de Bourgogne, Dijon, France
| | - P Sagot
- Service de Gynécologie-Obstétrique, Hôpital François Mitterrand, Université de Bourgogne, Dijon, France
| | | | - P Fauque
- Laboratoire de Biologie de la Reproduction, Hôpital François Mitterrand, Université de Bourgogne, Dijon, France.,INSERM UMR1231, Université de Bourgogne Franche comté, Dijon, France
| |
Collapse
|
8
|
Choux C, Binquet C, Carmignac V, Bruno C, Chapusot C, Barberet J, Lamotte M, Sagot P, Bourc’his D, Fauque P. The epigenetic control of transposable elements and imprinted genes in newborns is affected by the mode of conception: ART versus spontaneous conception without underlying infertility. Hum Reprod 2017; 33:331-340. [DOI: 10.1093/humrep/dex366] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2017] [Accepted: 11/22/2017] [Indexed: 12/12/2022] Open
|
9
|
Carmignac V, Dupont JM, Fierro RC, Barberet J, Bruno C, Lieury N, Dulioust E, Auger J, Fauque P. Diagnostic genetic screening for assisted reproductive technologies patients with macrozoospermia. Andrology 2017; 5:370-380. [DOI: 10.1111/andr.12311] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2016] [Revised: 11/04/2016] [Accepted: 11/07/2016] [Indexed: 12/12/2022]
Affiliation(s)
- V. Carmignac
- Equipe GAD; Génétique des Anomalies du Développement; Université de Bourgogne; Dijon France
| | - J.-M. Dupont
- Laboratoire de Cytogénétique Constitutionnelle; Faculté de Médecine; Hôpitaux Universitaires Paris Centre; Université Paris Descartes; Paris France
| | - R. C. Fierro
- Laboratoire de Microscopie; Université Lorraine; Nancy France
- Sciences de la Santé; Université Autonome Métropolitaine; Mexico City Mexico
| | - J. Barberet
- Service de Biologie de la Reproduction; Hôpital François Mitterrand; Université de Bourgogne; Dijon France
| | - C. Bruno
- Service de Biologie de la Reproduction; Hôpital François Mitterrand; Université de Bourgogne; Dijon France
| | - N. Lieury
- Service de Biologie de la Reproduction; Hôpital François Mitterrand; Université de Bourgogne; Dijon France
| | - E. Dulioust
- Service d'Histologie-Embryologie; Biologie de la Reproduction/CECOS; Hôpitaux Universitaires Paris Centre; Paris France
- INSERM U1016; Equipe ‘Génomique, Epigénétique et Physiologie de la Reproduction’; Institut Cochin; Université Paris Descartes; Paris France
| | - J. Auger
- Service d'Histologie-Embryologie; Biologie de la Reproduction/CECOS; Hôpitaux Universitaires Paris Centre; Paris France
- INSERM U1016; Equipe ‘Génomique, Epigénétique et Physiologie de la Reproduction’; Institut Cochin; Université Paris Descartes; Paris France
| | - P. Fauque
- Equipe GAD; Génétique des Anomalies du Développement; Université de Bourgogne; Dijon France
- Service de Biologie de la Reproduction; Hôpital François Mitterrand; Université de Bourgogne; Dijon France
| |
Collapse
|
10
|
Bruno C, Dudkiewicz-Sibony C, Berthaut I, Weil E, Brunet L, Fortier C, Pfeffer J, Ravel C, Fauque P, Mathieu E, Antoine J, Kotti S, Mandelbaum J. Survey of 243 ART patients having made a final disposition decision about their surplus cryopreserved embryos: the crucial role of symbolic embryo representation. Hum Reprod 2016; 31:1508-14. [DOI: 10.1093/humrep/dew104] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2015] [Accepted: 04/13/2016] [Indexed: 12/16/2022] Open
|
11
|
Bruno C, Carmignac V, Netchine I, Choux C, Duffourd Y, Faivre L, Thauvin-Robinet C, Le Bouc Y, Sagot P, Bourc'his D, Fauque P. Germline correction of an epimutation related to Silver-Russell syndrome. Hum Mol Genet 2015; 24:3314-21. [DOI: 10.1093/hmg/ddv079] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2015] [Accepted: 02/26/2015] [Indexed: 12/23/2022] Open
|
12
|
Bouillon C, Fauque P. Devenir des enfants issus des techniques d’assistance médicale à la procréation. Arch Pediatr 2013; 20:575-9. [DOI: 10.1016/j.arcped.2013.02.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2013] [Revised: 01/30/2013] [Accepted: 02/19/2013] [Indexed: 12/01/2022]
|
13
|
Pont JC, Patrat C, Fauque P, Camp ML, Gayet V, Wolf JP. [Pre-washing catheter dramatically improves the post intrauterine insemination pregnancy rate]. ACTA ACUST UNITED AC 2012; 40:356-9. [PMID: 22503402 DOI: 10.1016/j.gyobfe.2012.02.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2011] [Accepted: 09/06/2011] [Indexed: 10/28/2022]
Abstract
OBJECTIVE To analyze the effectiveness of pre-washing the intrauterine insemination catheters on IUI outcome. PATIENTS AND METHODS Infertile couples (n=322) involved in a IUI program were included in the study. IUI indications were cervical factors, ovulation dysfunction, cryopreserved semen and unexplained infertility. Every other week for two years, IUI catheters were washed with culture medium prior to intrauterine sperm insemination. RESULT(S) Only the first IUI for each couple were analyzed. Washing the catheter, prior to use, resulted in a 49.7% increase in clinical pregnancy rate (22.0% vs 14.7% P<0.05). This result is observed with fresh sperm (15.7% vs 11.1%) and frozen-thawed sperm as well (31.1% vs 19.8%). The early pregnancy termination rate was similar in all groups. DISCUSSION AND CONCLUSION Pre-washing the catheter before IUI should be recommended in Good Laboratory Practice Guidelines as it is already the case for embryo transfer catheters. This raises the problem of washing all single-use devices, in contact with gametes or embryos during IVF.
Collapse
Affiliation(s)
- J-C Pont
- Service d'histologie embryologie biologie de la reproduction, université Paris Descartes, 123, boulevard Port-Royal, 75014 Paris, France
| | | | | | | | | | | |
Collapse
|
14
|
Zernicka-Goetz M, Patrat C, Okamoto I, Thepot D, Peynot N, Fauque P, Daniel N, Diabangouaya P, Renard J, Duranthon V, Heard E. INVITED SESSION, SESSION 64: EPIGENETICS AND EARLY EVENTS DURING MAMMALIAN DEVELOPMENT Wednesday 6 July 2011 12:00 - 13:00. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.64] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Ocal P, Sahmay S, Irez T, Senol H, Cepni I, Purisa S, Lin W, Liu X, Donjacour A, Maltepe E, Rinaudo P, Baumgarten MN, Stoop D, Haentjes P, Verheyen G, De Schrijver F, Liebaers I, Camus M, Bonduelle M, Devroey P, Nelissen ECM, Van Montfoort APA, Coonen E, Derhaag JG, Evers JLH, Dumoulin JCM, Costa Lopes JR, Mendes dos Santos J, Portugal Silva Lima S, Portugal Silva Souza S, Rodrigues Pereira T, Barguil Brasileiro JP, Pina H, Lessa ML, Genovese Soares M, Medina Lopes V, Ribeiro CG, Adami K, Hughes C, Emerson G, Grundy K, Kelly P, Mocanu E, Rodrigues Pereira T, Medina Lopes V, Barguil Brasileiro JP, Coelho Cafe T, de Souza Costa JBM, Zavattiero Tierno NI, Portugal Silva Lima S, Portugal Silva Souza S, Mendes dos Santos J, Costa Lopes JR, Rinaudo P, Lin W, Liu X, Donjacour A, Singh S, Vitthala S, Zosmer A, Sabatini L, Tozer A, Davis C, Al-Shawaf T, Neri QV, Monahan D, Rosenwaks Z, Palermo GD, Kalu E, Thum MY, Abdalla HA, Sazonova A, Bergh C, Kallen K, Thurin-Kjellberg A, Wennerholm UB, Griesinger G, Doody K, Witjes H, Mannaerts B, Tarlatzis B, Witjes H, Mannaerts B, Rombauts L, Heijnen E, Marintcheva-Petrova M, Elbers J, Koning A, Mutsaerts MAQ, Hoek A, Mol BW, Fadini R, Guarnieri T, Mignini Renzini M, Comi R, Mastrolilli M, Villa A, Colpi E, Coticchio G, Dal Canto M, Dolleman M, Broer SL, Opmeer BC, Fauser BC, Mol BW, Broekmans FJM, Alama P, Requena A, Crespo J, Munoz M, Ballesteros A, Munoz E, Fernandez M, Meseguer M, Garcia-Velasco JA, Pellicer A, Munk M, Smidt-Jensen S, Blaabjerg J, Christoffersen C, Lenz S, Lindenberg S, Bosch E, Labarta E, Cruz F, Simon C, Remohi J, Pellicer A, Esler J, Osborn J, Boissonnas Chalas C, Marszalek A, Fauque P, Wolf JP, De Ziegler D, Cabanes L, Jouannet P, Han AR, Park CW, Cha SW, Kim HO, Yang KM, Kim JY, Song IO, Koong MK, Kang IS, Roszaman R, Omar MH, Nazri Y, Azantee YW, Murad AZ, Zainulrashid MR, Wang N, Le F, Wang LY, Ding GL, Sheng JZ, Huang HF, Jin F, Reinblatt S, Holzer H, Son WY, Shalom-Paz E, Chian RC, Buckett W, Dahan M, Demirtas E, Tan SL, Revel A, Schejter-Dinur Y, Revel-Vilk S, Hermens RPMG, van den Boogaard E, Leschot NJ, Vollebergh JHA, Bernardus R, Kremer JAM, van der Veen F, Goddijn M, Nahuis MJ, Kose N, Bayram N, Hompes PGA, Mol BWJ, van der veen F, van Wely M, Van Disseldorp J, Broer SL, Dolleman MD, Broeze K, Opmeer BC, Mol BW, Broekmans FJM, De Rycke M, Petrussa L, Liebaers I, Van de Velde H, Cerrillo M, Pacheco A, Rodriguez S, Gomez R, Delagado F, Pellicer A, Garcia Velasco JA, Desmyttere S, Verpoest W, De Rycke M, Staessen C, De Vos A, Liebaers I, Bonduelle M, Kohls G, Ruiz FJ, De la Fuente G, Toribio M, Martinez M, Pellicer A, Garcia-Velasco JA, Soderstrom - Anttila V, Salevaara M, Suikkari AM, Clua E, Tur R, Alcaniz N, Boada M, Rodriguez I, Barri PN, Veiga A, Nelen WLDM, Van Empel IWH, Cohlen BJ, Laven JS, Aarts JWM, Kremer JAM, Ricciarelli E, Gomez-Palomares JL, Andres-Criado L, Hernandez ER, Courbiere B, Aye M, Perrin J, Di Giorgio C, De Meo M, Botta A, Castilla Alcala J, Luceno Maestre F, Cabello Y, Gomez-Palomares JL, Hernandez J, Marqueta J, Pareja A, Hernandez E, Coroleu B, Helmgaard L, Klein BM, Arce JC, Aarts JWM, van Empel IWH, Boivin J, Kremer JAM, Verhaak CM, Ding G, Yin R, Wang N, Sheng J, Huang H, Mancini F, Tur R, Gomez MJ, Rodriguez I, Coroleu B, Barri PN, van den Boogaard NM, van der Steeg JW, van der Veen F, Hompes P, Mol BW, Boyer P, Gervoise-Boyer M, Meddeb L, Rossin B, Audibert F, Sakian S, Chan Wong E, Ma S, Pathak R, Mustafa MD, Ahmed RS, Tripathi AK, Guleria K, Banerjee BD, Vela G, Luna M, Flisser ED, Sandler B, Brodman M, Grunfeld L, Copperman AB, Baronio M, Carrascosa P, Capunay C, Vallejos J, Papier S, Borghi M, Sueldo C, Carrascosa J, Martin Lopez E, Marcucci A, Marcucci I, Salacone P, Sebastianelli A, Caponecchia L, Pacini N, Rago R, Alvarez M, Carreras O, Gomez MJ, Tur R, Coroleu B, Barri PN, Arnoldi M, Diaferia D, Corbucci MG, De Lauretis L, Kook MJ, Jung JY, Lee JH, Jung YJ, Hwang HK, Kang A, An SJ, Kim HM, Kwon HC, Lee SJ, Satoh M, Imada J, Ito K, Migishima F, Inoue T, Ohnishi Y, Kawato H, Nakaoka Y, Fukuda A, Morimoto Y, Mourad S, Hermens RPMG, Nelen WLDM, Grol RPTM, Kremer JAM, Polyzos NP, Valachis A, Patavoukas E, Papanikolaou EG, Messinis IE, Tarlatzis BC, Kang H, Kim CH, Park E, Kim S, Chae HD, Kang BM, Jung KS, Song HJ, Ahn YS, Petkova L, Canov I, Milachich T, Shterev A, Patrat C, Fauque P, Pocate K, Juillard JC, Gayet V, Blanchet V, de Ziegler D, Wolf JP, van der JW, Leushuis E, Steures P, Koks C, Oosterhuis J, Bourdrez P, Bossuyt PM, van der Veen F, Mol BWJ, Hompes PGA. Posters * Safety & Quality (I.E. Guidelines, Multiple Pregnancy, Outcome, Follow-Up etc.). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.310] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
16
|
Abstract
The causes of male infertility may be identified, with the possibility of drugs treatment, or they may be idiopathic, for which treatments are at the research stage. The treatments available aim to increase the quantity and quality of spermatozoa produced by increasing their fertilising capacity and protecting their nuclear structure. Hormone treatments - recombinant FSH, purified FSH - give different results depending on whether studies examine semen parameters or fertilisation and pregnancy rates. In the case of non-hormone treatments (folates, zinc, vitamins E or C, selenium, glutathione and carnitine), the data in the literature is also contradictory and there is no clear consensus of opinion. However, the studies make use of highly variable methodologies and many of them are non-randomised. In terms of hygiene and dietary measures, tobacco, alcohol and excess weight have a negative effect on semen parameters and it is relevant to encourage patients to adopt a healthier lifestyle.
Collapse
Affiliation(s)
- P Fauque
- Service d'histologie-embryologie et biologie de la reproduction, groupe hospitalier Cochin - Saint-Vincent-de-Paul, 123, boulevard de Port-Royal, 75674 Paris cedex 14, France.
| |
Collapse
|
17
|
Crippa A, Magli MC, Robles F, Capoti A, Ferraretti AP, Gianaroli L, Gallina A, Bonaparte E, Moretti M, Colpi GM, Nerva F, Contalbi G, Vacalluzzo L, Tabano S, Grati FR, Gazzano G, Sirchia SM, Simoni G, Miozzo M, Handyside A, Gabriel A, Thornhill AR, Clemente E, Reitter C, Affara N, Griffin DK, Macek M, Feldmar P, Kluckova H, Hrehorcak M, Diblik J, Paulasova P, Turnovec M, Vilimova S, Macek M, Fontes L, Haddad L, Borges E, Iaconelli A, Braga DPAF, Vianna-Morgante AM, Komsky A, Kasterstein E, Komarovsky D, Bern O, Maslansky B, Kaplan T, Raziel A, Friedler S, Gidoni Y, Ben-Ami I, Ron-El R, Strassburger D, Maggiulli R, Monahan D, Neri QV, Hu JCY, Rosenwaks Z, Palermo GD, Beyazyurek C, Ekmekci GC, Tac HA, Ajredin N, Verlinsky O, Fiorentino F, Kahraman S, Camp M, Hesters L, Le Lorc'h M, Frydman R, Romana S, Frydman N, Perez Sanz J, Matorras R, Arluzea J, Romin Y, Bilbao J, Gonzalez-Santiago N, Manova-Todorova K, Koff A, Rivera-Pomar JM, de la Hoz-Torres C, Xanthopoulou L, Ghevaria H, Mantzouratou A, Serhal P, Doshi A, Delhanty JD, Ye Y, Qian Y, Jin F, Munne S, Gutierrez C, Wagner C, Hill D, Wiemer K, Fischer J, Kaplan B, Danzer H, Surrey M, Opsahl M, Hladikova B, Sobek A, Tkadlec E, Kyselova K, Sobek A, Nichi M, Figueira RCS, Braga DPAF, Setti AS, Iaconelli A, Borges E, Colturato SS, Setti AS, Figueira RCS, Braga DPAF, Iaconelli A, Borges E, Rubio C, Domingo J, Rodrigo L, Mercader A, De los Santos MJ, Pehlivan T, Bosch E, Fernandez M, Simon C, Remohi J, Pellicer A, Perez-Nevot B, Lendinez AM, Palomares AR, Polo M, Rodriguez A, Reche A, Ruiz-Galdon M, Reyes-Engel A, Knauff EAH, Blauw HM, Kok K, Wijmenga C, Fauser BCJM, Franke L, Paffoni A, Paracchini V, Ferrari S, Restelli L, Coviello DA, Scarduelli C, Seia M, Ragni G, Aoyama N, Takehara Y, Kawachiya S, Kuroda T, Kawasaki N, Yamadera R, Suzuki T, Kato K, Kato O, Xu QH, Zhang ZG, Zhou P, Wei ZL, Huang DK, Xing Q, Cao YX, Fauque P, Ripoche MA, Tost J, Journot L, Jouannet P, Vaiman D, Dandolo L, Jammes H, Hellani A, Elsheikh A, Abuamero KK, Elakoum S, Palomares AR, Lendinez AM, Perez-Nevot B, Martinez F, Perez de la Blanca E, Ruiz-Galdon M, Reyes-Engel A, Sobek A, Hladikova B, Tkadlec E, Koutna O, Cepelak T, Kyselova K, Sobek AJR. Posters * Reproductive Genetics (PGD/PGS). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Fauque P, Jouannet P, Jammes H. [Parental imprinting related to Assisted Reproductive Technologies]. ACTA ACUST UNITED AC 2008; 36:1139-46. [PMID: 18922729 DOI: 10.1016/j.gyobfe.2008.08.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2008] [Accepted: 08/20/2008] [Indexed: 11/17/2022]
Abstract
Until the introduction of Assisted Reproductive Technologies (ART), many studies were conducted in order to evaluate their impact upon the children's health born in such a way. The epigenetic-risk notion was invoked and a link between ART and diseases associated with imprinting alterations was suggested with different examples, such as Beckwith-Wiedemann syndrome (BWS), Angelman syndrome (AS) and Silver-Russell syndrome (SRS). The epigenetic "life cycle" of imprinting (germline erasure, germline establishment, and somatic maintenance) concerns all the phases from gametogenesis, gamete maturation, fertilization, to early embryo development and appears particularly vulnerable to perturbations induced by superovulation, in vitro fertilization, embryo culture and embryo transfer. The studies, performed in model animal, provide a basis of the understanding of imprinting alterations induced by the ART and clinically useful information in order to improve the ART.
Collapse
Affiliation(s)
- P Fauque
- Laboratoire de Biologie de la Reproduction, Hôpital Cochin, Université Paris Descartes, 75014 Paris, France.
| | | | | |
Collapse
|
19
|
Page K, Guibert J, Weitzen S, Davy C, Fauque P, Olivennes F. Administering Estradiol Vaginally in Preparatory Artificial Cycles for Frozen/Thawed Embryo Transfer is Advantageous in Priming the Endometrium for Implantation in Patients With Thin Endometria. Fertil Steril 2005. [DOI: 10.1016/j.fertnstert.2005.07.449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
20
|
Roux C, Fauque P, Joanne C, Tripogney C, Agnani G, Bresson J. Trypan blue staining: A quick test to attest the quality of ovarian cryopreservation. Fertil Steril 2004. [DOI: 10.1016/j.fertnstert.2004.07.296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|